Form 4: Maravai LifeSciences CEO Sells Shares to Cover Tax Obligations

Maravai LifeSciences CEO William E. Martin III sold 160,981 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• William E. Martin III, the CEO of Maravai LifeSciences Holdings, Inc., sold 160,981 shares of Class A Common Stock on January 15, 2025.
• The sale was executed at a price of $4.56 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock unit awards.
• Following the transaction, Mr. Martin directly owns 828,449 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold and the price are specific to the individual's compensation package and the company's stock performance.
• Similar transactions are regularly reported by executives at comparable companies in the biotech and life sciences sectors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.
• The sale does not indicate any change in the CEO's confidence in the company.

Key Dates

Keywords

Maravai LifeSciences, MRVI, William E. Martin III, stock sale, insider trading, Form 4, tax obligations, restricted stock units